(Q38987093)

English

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

0 references

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis (English)

1 reference

Europe PubMed Central

8 September 2017

1 reference

based on heuristic

inferred from title

Crohn's disease

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Remo Panaccione

7

object named as

Remo Panaccione

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Stephanie Coward

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M Ellen Kuenzig

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Fiona Clement

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Kerry McBrien

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Rebecca Holmes

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Cynthia H Seow

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ali Rezaie

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Gilaad G Kaplan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

31 January 2017

1 reference

Europe PubMed Central

8 September 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

461-472

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

The global burden of IBD: from 2015 to 2025.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Inflammatory bowel disease: a Canadian burden of illness review

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Management of Crohn's disease in adults.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Bayesian methods for evidence synthesis in cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: a multicentre, double-blind, randomized, parallel-group Phase II study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Identifiers

10.1097/MIB.0000000000001023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38987093&oldid=1981066227"